How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms

키워드

참고문헌 (122)

1. Sundsted KK, "Preanesthesia medical evaluation for electroconvulsive therapy : a review of the literature", J ECT, 30, pp.35~42 (2014)
2. Hoirisch-Clapauch S, "Pivotal role of tissue plasminogen activator in the mechanism of action of electroconvulsive therapy", J Psychopharmacol, 28, pp.99~105 (2014)
3. Medda P, "The mood-stabilizing effects of electroconvulsive therapy", J ECT, 30, pp.275~282 (2014)
4. Sadock BJ, "Kaplan and Sadock’s comprehensive textbook of psychiatry" (2009), Lippincott Williams & Wilkins
5. Swartz CM, "A mechanism of seizure induction by electricity and its clinical implications", J ECT, 30, pp.94~97 (2014)
6. Takano H, "Differences in cerebral blood flow between missed and generalized seizures with electroconvulsive therapy : a positron emission tomographic study", Epilepsy Res, 97, pp.225~228 (2011)
7. Deng ZD, "Controlling stimulation strength and focality in electroconvulsive therapy via current amplitude and electrode size and spacing : comparison with magnetic seizure therapy", J ECT, 29, pp.325~335 (2013)
8. Enev M, "Imaging onset and propagation of ECTinduced seizures", Epilepsia, 48, pp.238~244 (2007)
9. Kranaster L, "Burst suppression: a more valid marker of postictal central inhibition?", J ECT, 29, pp.25~28 (2013)
10. Takano H, "Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression : positron emission tomographic study", Br J Psychiatry, 190, pp.63~68 (2007)
11. Allen P, "Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis", Am J Psychiatry, 173, pp.392~399 (2016)
12. Hua J, "Abnormal grey matter arteriolar cerebral blood volume in schizophrenia measured with 3D inflow-based vascularspace-occupancy MRI at 7T", Schizophr Bull, 43, pp.620~632 (2017)
13. Berggren Å, "A long-term follow-up of clinical response and regional cerebral blood flow changes in depressed patients treated with ECT", J Affect Disord, 167, pp.235~243 (2014)
14. Hosokawa T, "Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.243~250 (2009)
15. Suwa T, "Corticolimbic balance shift of regional glucose metabolism in depressed patients treated with ECT", J Affect Disord, 136, pp.1039~1046 (2012)
16. Nobler MS, "Decreased regional brain metabolism after ect", Am J Psychiatry, 158, pp.305~308 (2001)
17. Yatham LN, "A preliminary study of the effects of electroconvulsive therapy on regional brain glucose metabolism in patients with major depression", J ECT, 16, pp.171~176 (2000)
18. Mervaala E, "SPECT and neuropsychological performance in severe depression treated with ECT", J Affect Disord, 66, pp.47~58 (2001)
19. Bonne O, "Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy", J Nucl Med, 37, pp.1075~1080 (1996)
20. Andrade C, "Electroconvulsive therapy, hyper tensive surge, blood-brain barrier breach, and amnesia:exploring the evidence for a connection", J ECT, 30, pp.160~164 (2014)
21. Sackeim HA, "The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome", Arch Gen Psychiatry, 53, pp.814~824 (1996)
22. Fink M, "EEG changes with antipsychotic drugs", Am J Psychiatry, 159, pp.439~ (2002)
23. Folkerts H, "The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy", Eur Arch Psychiatry Clin Neurosci, 246, pp.155~164 (1996)
24. Krystal AD, "The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram : an intraindividual crossover study", Biol Psychiatry, 34, pp.759~767 (1993)
25. Wahlund B, "Seizure(Ictal)--EEG characteristics in subgroups of depressive disorder in patients receiving electroconvulsive therapy(ECT)--a preliminary study and multivariate approach", Comput Intell Neurosci, 2009, pp.965209~ (2009)
26. Zhao L, "Effects of modified electroconvulsive therapy on the electroencephalogram of schizophrenia patients", Springerplus, 5, pp.1063~ (2016)
27. McCormick LM, "Antipsychotic effect of electroconvulsive therapy is related to normalization of subgenual cingulate theta activity in psychotic depression", J Psychiatr Res, 43, pp.553~560 (2009)
28. Segi-Nishida E, "Exploration of new molecular mechanisms for antidepressant actions of electroconvulsive seizure", Biol Pharm Bull, 34, pp.939~944 (2011)
29. Rosenquist PB, "The antipsychotic effects of ECT : a review of possible mechanisms", J ECT, 30, pp.125~131 (2014)
30. Baldinger P, "Neurotransmitters and electroconvulsive therapy", J ECT, 30, pp.116~121 (2014)
31. Dyrvig M, "Temporal gene expression profile after acute electroconvulsive stimulation in the rat", Gene, 539, pp.8~14 (2014)
32. Kaneko T, "Microarray analysis of human blood during electroconvulsive therapy", J ECT, 31, pp.234~237 (2015)
33. de Jong JO, "Epigenetic effects of electroconvulsive seizures", J ECT, 30, pp.152~159 (2014)
34. Barreto G, "Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation", Nature, 445, pp.671~675 (2007)
35. Ma DK, "Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis", Science, 323, pp.1074~1077 (2009)
36. Jun H, "Gadd45b mediates electroconvulsive shock induced proliferation of hippocampal neural stem cells", Brain Stimul, 8, pp.1021~1024 (2015)
37. Jang SS, "Seizureinduced regulations of amyloid-, step61, and step61 substrates involved in hippocampal synaptic plasticity", Neural Plast, 2016, pp.2123748~ (2016)
38. Pusalkar M, "Acute and chronic electroconvulsive seizures (ecs) differentially regulate the expression of epigenetic machinery in the adult rat hippocampus", Int J Neuropsychopharmacol, 19, pp.pyw040~ (2016)
39. Tsankova NM, "Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures", J Neurosci, 24, pp.5603~5610 (2004)
40. Park HG, "Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex", Int J Neuropsychopharmacol, 17, pp.1487~1500 (2014)
41. Madsen TM, "Increased neurogenesis in a model of electroconvulsive therapy", Biol Psychiatry, 47, pp.1043~1049 (2000)
42. Ito M, "Effects of repeated electroconvulsive seizure on cell proliferation in the rat hippocampus", Synapse, 64, pp.814~821 (2010)
43. Kim Y, "Activation of Cdk2-pRB-E2F1 cell cycle pathway by repeated electroconvulsive shock in the rat frontal cortex", Biol Psychiatry, 57, pp.107~109 (2005)
44. Won Je Jeon, "Repeated electroconvulsive seizure induces c-Myc down-regulation and Bad inactivation in the rat frontal cortex", Experimental and Molecular Medicine, 40(4), pp.435~444 (2008), 생화학분자생물학회
45. Kondratyev A, "Electroconvulsive shock exposure prevents neuronal apoptosis after kainic acid-evoked status epilepticus", Brain Res Mol Brain Res, 91, pp.1~13 (2001)
46. Nilsson JA, "Myc pathways provoking cell suicide and cancer", Oncogene, 22, pp.9007~9021 (2003)
47. Brunoni AR, "BDNF blood levels after electroconvulsive therapy in patients with mood disorders : a systematic review and meta-analysis", World J Biol Psychiatry, 15, pp.411~418 (2014)
48. Hu Y, "The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression", J ECT, 26, pp.121~125 (2010)
49. Nibuya M, "ECT for the treatment of psychiatric symptoms in Basedow’s disease", J ECT, 18, pp.54~57 (2002)
50. Altar CA, "Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain", Biol Psychiatry, 54, pp.703~709 (2003)
51. Molendijk ML, "Serum BDNF concentrations as peripheral manifestations of depression : evidence from a systematic review and meta-analyses on 179 associations(N=9484)", Mol Psychiatry, 19, pp.791~800 (2014)
52. Polyakova M, "Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: systematic review and meta-analyses of the preclinical and clinical literature", PLoS One, 10, pp.e0141564~ (2015)
53. Rapinesi C, "Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels", Psychiatry Res, 227, pp.171~178 (2015)
54. Gedge L, "Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression", Front Psychiatry, 3, pp.12~ (2012)
55. Marano CM, "Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy : a pilot study in patients with major depression", J Clin Psychiatry, 68, pp.512~517 (2007)
56. Taliaz D, "Altered brain-derived neurotrophic factor expression in the ventral tegmental area, but not in the hippocampus, is essential for antidepressant-like effects of electroconvulsive therapy", Biol Psychiatry, 74, pp.305~312 (2013)
57. Stelzhammer V, "Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients", Eur Neuropsychopharmacol, 23, pp.1199~1207 (2013)
58. Kondratyev A, "The effects of repeated minimal electroconvulsive shock exposure on levels of mRNA encoding fibroblast growth factor-2 and nerve growth factor in limbic regions", Neuroscience, 114, pp.411~416 (2002)
59. Newton SS, "Gene profile of electroconvulsive seizures : induction of neurotrophic and angiogenic factors", J Neurosci, 23, pp.10841~10851 (2003)
60. Minelli A, "Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy", Acta Psychiatr Scand, 129, pp.461~466 (2014)
61. Schmidt HD, "Functional biomarkers of depression: diagnosis, treatment, and pathophysiology", Neuropsychopharmacology, 36, pp.2375~2394 (2011)
62. Liu X, "Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder", Psychiatry Res, 218, pp.54~60 (2014)
63. Clark-Raymond A, "VEGF and depression : a comprehensive assessment of clinical data", J Psychiatr Res, 47, pp.1080~1087 (2013)
64. Lin PY, "Decreased glial cell line-derived neurotrophic factor levels in patients with depression : a metaanalytic study", J Psychiatr Res, 63, pp.20~27 (2015)
65. Blumberg HP, "Influence of vascular endothelial growth factor variation on human hippocampus morphology", Biol Psychiatry, 64, pp.901~903 (2008)
66. Minelli A, "Vascular Endothelial Growth Factor(VEGF)serum concentration during electroconvulsive therapy(ECT)in treatment resistant depressed patients", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.1322~1325 (2011)
67. Jaumotte JD, "Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures", J Neurosci Res, 92, pp.1425~1433 (2014)
68. Zhang X, "Electroconvulsive therapy increases glial cell-line derived neurotrophic factor(GDNF)serum levels in patients with drug-resistant depression", Psychiatry Res, 170, pp.273~275 (2009)
69. Turner CA, "Fibroblast growth factor-2:an endogenous antidepressant and anxiolytic molecule?", Biol Psychiatry, 72, pp.254~255 (2012)
70. Bufalino C, "The role of immune genes in the association between depression and inflammation : a review of recent clinical studies", Brain Behav Immun, 31, pp.31~47 (2013)
71. Connor TJ, "Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge:a role for IFN-gamma?", Neurosci Lett, 441, pp.29~34 (2008)
72. Guloksuz S, "The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway", Brain Behav Immun, 48, pp.48~52 (2015)
73. Haskett RF, "Electroconvulsive therapy’s mechanism of action : neuroendocrine hypotheses", J ECT, 30, pp.107~110 (2014)
74. O’Brien JT, "A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects", Am J Psychiatry, 161, pp.2081~2090 (2004)
75. Edgar N, "A putative functional role for oligodendrocytes in mood regulation", Transl Psychiatry, 2, pp.e109~ (2012)
76. Wennström M, "Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures", Biol Psychiatry, 59, pp.178~186 (2006)
77. Hellsten J, "Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment", Eur J Neurosci, 16, pp.283~290 (2002)
78. Lillethorup TP, "Electroconvulsive shocks decrease 2-adrenoceptor binding in the Flinders rat model of depression", Eur Neuropsychopharmacol, 25, pp.404~412 (2015)
79. Nikisch G, "CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy", Eur Psychiatry, 23, pp.356~359 (2008)
80. Landau AM, "Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates", Neuropsychopharmacology, 36, pp.511~518 (2011)
81. Kautto M, "Serotonin transporter(5-HTTLPR)and norepinephrine transporter(NET)gene polymorphisms : susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression", Neurosci Lett, 590, pp.116~120 (2015)
82. WAY 100635, "Int J Neuropsychopharmacol", 2010, 785~791
83. Lanzenberger R, "Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET", Mol Psychiatry, 18, pp.93~100 (2013)
84. Goto S, "Is serotonergic function associated with the antidepressant effects of modified-electroconvulsive therapy?", J Affect Disord, 136, pp.1062~1066 (2012)
85. Yatham LN, "Effect of electroconvulsive therapy on brain 5-HT(2)receptors in major depression", Br J Psychiatry, 196, pp.474~479 (2010)
86. Ozsoy S, "The effects of antidepressants on neuropeptide Y in patients with depression and anxiety", Pharmacopsychiatry, 49, pp.26~31 (2016)
87. Altar CA, "Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways", J Neurosci, 24, pp.2667~2677 (2004)
88. Liu X, "FGF-2 induces neuronal death through upregulation of system xc-", Brain Res, 1547, pp.25~33 (2014)
89. Sartorius A, "Elevated spectroscopic glutamate", gamma-amino butyric acid in rats bred for learned helplessness, 2007, pp.18, 1469~1473
90. Hashimoto K, "Increased levels of glutamate in brains from patients with mood disorders", Biol Psychiatry, 62, pp.1310~1316 (2007)
91. Hasler G, "Reduced prefrontal glutamate", glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy, 2007, pp.64, 193~200
92. Pfleiderer B, "Effective electroconvulsive therapy reverses glutamate", glutamine deficit in the left anterior cingulum of unipolar depressed patients, 2003, pp.122, 185~192
93. Njau S, "Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression", J Psychiatry Neurosci, 41, pp.150177~ (2016)
94. Grimm S, "Region-specific glutamate changes in patients with unipolar depression", J Psychiatr Res, 46, pp.1059~1065 (2012)
95. Bernard R, "Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression", Mol Psychiatry, 16, pp.634~646 (2011)
96. Duric V, "Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects", Int J Neuropsychopharmacol, 16, pp.69~82 (2013)
97. Beneyto M, "Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia", Synapse, 60, pp.585~598 (2006)
98. Dong J, "Effects of electroconvulsive therapy and propofol on spatial memory and glutamatergic system in hippocampus of depressed rats", J ECT, 26, pp.126~130 (2010)
99. Michael N, "Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression", Psychol Med, 33, pp.1277~1284 (2003)
100. Lyden H, "Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression", Transl Psychiatry, 4, pp.e380~ (2014)
101. Ota M, "Effect of electroconvulsive therapy on gray matter volume in major depressive disorder", J Affect Disord, 186, pp.186~191 (2015)
102. Abbott CC, "Hippocampal structural and functional changes associated with electroconvulsive therapy response", Transl Psychiatry, 4, pp.e483~ (2014)
103. Joshi SH, "Structural plasticity of the hippocampus and amygdala induced by electroconvulsive therapy in major depression", Biol Psychiatry, 79, pp.282~292 (2016)
104. Cano M, "Modulation of limbic and prefrontal connectivity by electroconvulsive therapy in treatment-resistant depression : a preliminary study", Brain Stimul, 9, pp.65~71 (2016)
105. Jansson L, "Glial cell activation in response to electroconvulsive seizures", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.1119~1128 (2009)
106. Vaidya VA, "Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures", Neuroscience, 89, pp.157~166 (1999)
107. Hellsten J, "Electroconvulsive seizures induce angiogenesis in adult rat hippocampus", Biol Psychiatry, 58, pp.871~878 (2005)
108. Dukart J, "Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders", Proc Natl Acad Sci U S A, 111, pp.1156~1161 (2014)
109. Nordanskog P, "Increase in hippocampal volume after electroconvulsive therapy in patients with depression : a volumetric magnetic resonance imaging study", J ECT, 26, pp.62~67 (2010)
110. Tendolkar I, "Electroconvulsive therapy increases hippocampal and amygdala volume in therapy refractory depression : a longitudinal pilot study", Psychiatry Res, 214, pp.197~203 (2013)
111. Ten Doesschate F, "Pre-treatment amygdala volume predicts electroconvulsive therapy response", Front Psychiatry, 5, pp.169~ (2014)
112. Lekwauwa RE, "Hippocampal volume as a predictor of short-term ECT outcomes in older patients with depression", Am J Geriatr Psychiatry, 13, pp.910~913 (2005)
113. Kaiser RH, "Large-scale network dysfunction in major depressive disorder : a meta-analysis of resting-state functional connectivity", JAMA Psychiatry, 72, pp.603~611 (2015)
114. Gudayol-Ferré E, "Changes in brain connectivity related to the treatment of depression measured through fMRI : a systematic review", Front Hum Neurosci, 9, pp.582~ (2015)
115. Connolly CG, "Resting-state functional connectivity of subgenual anterior cingulate cortex in depressed adolescents", Biol Psychiatry, 74, pp.898~907 (2013)
116. Wang H, "Evidence of a dissociation pattern in default mode subnetwork functional connectivity in schizophrenia", Sci Rep, 5, pp.14655~ (2015)
117. Kraguljac NV, "Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone", Neuroimage Clin, 10, pp.146~158 (2015)
118. Leaver AM, "Modulation of intrinsic brain activity by electroconvulsive therapy in major depression", Biol Psychiatry Cogn Neurosci Neuroimaging, 1, pp.77~86 (2016)
119. Abbott CC, "Electroconvulsive therapy response in major depressive disorder : a pilot functional network connectivity resting state fMRI investigation", Front Psychiatry, 4, pp.10~ (2013)
120. Argyelan M, "Subgenual cingulate cortical activity predicts the efficacy of electroconvulsive therapy", Transl Psychiatry, 6, pp.e789~ (2016)
121. Beall EB, "Effects of electroconvulsive therapy on brain functional activation and connectivity in depression", J ECT, 28, pp.234~241 (2012)
122. Wolf RC, "Structural network changes in patients with major depression and schizophrenia treated with electroconvulsive therapy", Eur Neuropsychopharmacol, 26, pp.1465~1474 (2016)

관련 논문AI추천